Nano Mobile Healthcare, Inc. engages in the development of detection devices. The company is headquartered in Boston, Massachusetts and currently employs 3 full-time employees. The company went IPO on 2011-02-23. The Company’s first products are the convergence of nano-electronics, bio-informatics, and wireless technology. The products are based on patented technology invented by the National Aeronautics and Space Administration (NASA), which is license to Nanobeak, and further sub-licensed to the Company. The firm is focused on its screening for the presence of disease or the use of drugs.
最新の財務諸表(Form-10K)によると、Nano Mobile Healthcare Incの総資産は$0で、純損失は$0です。
VNTHの主要な財務比率は何ですか?
Nano Mobile Healthcare Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Nano Mobile Healthcare Incの収益はセグメントまたは地域別にどのように分けられていますか?
Nano Mobile Healthcare Inc の最大収益セグメントは Investment and Related Activities で、最新の利益発表における収益は 201,252,000 です。地域別に見ると、United States が Nano Mobile Healthcare Inc の主要市場であり、収益は 201,252,000 です。
Nano Mobile Healthcare Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Nano Mobile Healthcare Incの純損失は$0です。